| http://dbpedia.org/ontology/abstract
|
Rutherford Health was a private oncology p … Rutherford Health was a private oncology provider founded by Mike Moran and Karol Sikora in 2015, with investment from Neil Woodford and the Wales Life Sciences Investment Fund, to develop proton therapy facilities in the United Kingdom and elsewhere. Until 2019 it was known as Proton Partners International. It went into liquidation in June 2022. According to major shareholder Schroders UK Public Private Trust, the company had pursued a "flawed expansion strategy ... from 2015 to 2019" leading to "a high and unsustainable cash burn".g to "a high and unsustainable cash burn".
|
| http://dbpedia.org/ontology/wikiPageID
|
52673665
|
| http://dbpedia.org/ontology/wikiPageLength
|
10192
|
| http://dbpedia.org/ontology/wikiPageRevisionID
|
1122790025
|
| http://dbpedia.org/ontology/wikiPageWikiLink
|
http://dbpedia.org/resource/Reading%2C_Berkshire +
, http://dbpedia.org/resource/Taunton +
, http://dbpedia.org/resource/Ion_Beam_Applications +
, http://dbpedia.org/resource/Bedlington%2C_Northumberland +
, http://dbpedia.org/resource/Interserve +
, http://dbpedia.org/resource/Karol_Sikora +
, http://dbpedia.org/resource/Oncology +
, http://dbpedia.org/resource/Schroders_UK_Public_Private_Trust +
, http://dbpedia.org/resource/Wales_Audit_Office +
, http://dbpedia.org/resource/Liverpool +
, http://dbpedia.org/resource/Shawbrook_Bank +
, http://dbpedia.org/resource/Somerset_NHS_Foundation_Trust +
, http://dbpedia.org/resource/Category:Companies_of_Wales +
, http://dbpedia.org/resource/Category:Health_care_companies_of_the_United_Kingdom +
, http://dbpedia.org/resource/Proton_therapy +
, http://dbpedia.org/resource/Knowledge_Quarter%2C_Liverpool +
, http://dbpedia.org/resource/Clinical_trial +
, http://dbpedia.org/resource/Neil_Woodford +
, http://dbpedia.org/resource/Newport%2C_Wales +
, http://dbpedia.org/resource/Abu_Dhabi +
|
| http://dbpedia.org/property/wikiPageUsesTemplate
|
http://dbpedia.org/resource/Template:Reflist +
, http://dbpedia.org/resource/Template:Short_description +
|
| http://purl.org/dc/terms/subject
|
http://dbpedia.org/resource/Category:Health_care_companies_of_the_United_Kingdom +
, http://dbpedia.org/resource/Category:Companies_of_Wales +
|
| http://www.w3.org/ns/prov#wasDerivedFrom
|
http://en.wikipedia.org/wiki/Rutherford_Health?oldid=1122790025&ns=0 +
|
| http://xmlns.com/foaf/0.1/isPrimaryTopicOf
|
http://en.wikipedia.org/wiki/Rutherford_Health +
|
| owl:sameAs |
http://www.wikidata.org/entity/Q28407191 +
, https://global.dbpedia.org/id/2dezP +
, http://dbpedia.org/resource/Rutherford_Health +
|
| rdfs:comment |
Rutherford Health was a private oncology p … Rutherford Health was a private oncology provider founded by Mike Moran and Karol Sikora in 2015, with investment from Neil Woodford and the Wales Life Sciences Investment Fund, to develop proton therapy facilities in the United Kingdom and elsewhere. Until 2019 it was known as Proton Partners International. It went into liquidation in June 2022. According to major shareholder Schroders UK Public Private Trust, the company had pursued a "flawed expansion strategy ... from 2015 to 2019" leading to "a high and unsustainable cash burn".g to "a high and unsustainable cash burn".
|
| rdfs:label |
Rutherford Health
|
